Tu Thomas's Form 4 filing
Inari Medical, Inc. (NARI) · filed Jan 31, 2023
- Accession no.
- 0001127602-23-002745
- Filed
- Jan 31, 2023, 4:28 PM ET
- Trade date
- Jan 27, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $606.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tu ThomasCIK 0001806426 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 27, 2023 | Common Stock | MOption exerciseAcquired | +10,000 | $0.457 | +$4,570 | 95,700 | Direct | |
| Jan 27, 2023 | Common Stock | SSaleDisposed | −2,699 | $58.32F2 | −$157,405.68 | 93,001 | Direct | |
| Jan 27, 2023 | Common Stock | SSaleDisposed | −2,130 | $59.88F3 | −$127,544.4 | 90,871 | Direct | |
| Jan 27, 2023 | Common Stock | SSaleDisposed | −700 | $60.77F4 | −$42,539 | 90,171 | Direct | |
| Jan 27, 2023 | Common Stock | SSaleDisposed | −3,071 | $62.06F5 | −$190,586.26 | 87,100 | Direct | |
| Jan 27, 2023 | Common Stock | SSaleDisposed | −1,100 | $63.31F6 | −$69,641 | 86,000 | Direct | |
| Jan 27, 2023 | Common Stock | SSaleDisposed | −300 | $63.94F7 | −$19,182 | 85,700 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 27, 2023 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 149,584 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $58.40 to $59.38 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $59.43 to $60.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $60.44 to $61.34 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $61.57 to $62.56 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $62.83 to $63.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $63.83 to $64.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.